Related Experiment Video

Updated: Aug 15, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

Prenatal alcohol exposure and offspring hyperactivity: effects of para-chlorophenylalanine and methysergide

N W Bond

    Neurobehavioral Toxicology and Teratology
    |November 1, 1986
    PubMed

    Insights

    Fetal alcohol exposure causes hyperactivity in pups, but this is not due to changes in the serotonin system. Further research is needed to understand the mechanisms behind alcohol-induced hyperactivity.

    Area of Science:

    • Neuroscience
    • Developmental Biology
    • Pharmacology

    Background:

    • Prenatal alcohol exposure is a known cause of developmental abnormalities.
    • Hyperactivity is a common behavioral outcome in children exposed to alcohol in utero.
    • The underlying neurobiological mechanisms of this hyperactivity remain unclear.

    Purpose of the Study:

    • To investigate the role of the serotonergic system in mediating hyperactivity observed after prenatal alcohol exposure.
    • To examine the effects of para-chlorophenylalanine and methysergide on activity levels in rats exposed to alcohol during gestation.

    Main Methods:

    • Pregnant Wistar rats were administered ethanol or a control diet during gestation.
    • Pups were tested for activity levels at different ages after administration of para-chlorophenylalanine or methysergide.
    • Behavioral responses were compared between alcohol-exposed and control groups.

    Main Results:

    • Prenatal alcohol exposure led to increased activity in 16-day-old pups.
    • Para-chlorophenylalanine administration increased activity, but its effects were independent of prenatal alcohol exposure.
    • Methysergide decreased activity in a dose-dependent manner, with similar effects across all prenatal treatment groups.

    Conclusions:

    • The hyperactivity associated with fetal alcohol exposure is unlikely to stem from alterations in the ontogeny of the serotonergic system involved in response inhibition.
    • These findings suggest that other neurobiological pathways may be responsible for alcohol-induced hyperactivity.

    More Related Videos

    Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development15:27

    Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development

    Published on: July 13, 2014

    Moderate Prenatal Alcohol Exposure and Quantification of Social Behavior in Adult Rats11:01

    Moderate Prenatal Alcohol Exposure and Quantification of Social Behavior in Adult Rats

    Published on: December 14, 2014

    Related Concept Videos

    Teratogenicity01:07

    Teratogenicity

    The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
    Drugs Affecting Neurotransmitter Synthesis01:29

    Drugs Affecting Neurotransmitter Synthesis

    Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
    Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

    Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

    The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
    A study on guinea pigs examined the...
    Attention-Deficit/Hyperactivity Disorder01:30

    Attention-Deficit/Hyperactivity Disorder

    Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
    Diagnostic Criteria and Symptoms
    To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.